Black Ant recall
Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
Why was Black Ant recalled?
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots
- Product
- Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
- Recalling firm
- Eugene Oregon, Inc.
- Quantity
- 136 boxes
- Distribution
- To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC
- Recall date
- October 8, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)